AF
Avanza Fonder Portfolio holdings
AUM
$3.61B
1-Year Est. Return
26.67%
This Fund
S&P 500
1 Year Est. Return
+26.67%
AUM
$3.61B
AUM Growth
-$328M
(-8.3%)
Holding
513
Top Buys
| 1 | +$2.09M | |
| 2 | +$2.03M | |
| 3 | +$1.82M | |
| 4 |
Lam Research
LRCX
|
+$1.72M |
| 5 |
Applied Materials
AMAT
|
+$1.62M |
Top Sells
| 1 | +$35.4M | |
| 2 | +$13.5M | |
| 3 | +$13.3M | |
| 4 |
Broadcom
AVGO
|
+$7.09M |
| 5 |
Amazon
AMZN
|
+$5.26M |
Sector Composition
| 1 | Technology | 32.67% |
| 2 | Financials | 13.22% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Communication Services | 11.62% |
| 5 | Healthcare | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Mirum Pharmaceuticals
MIRM
$5.76B
| – | – |
-2,677
|
|
||
502
NewAmsterdam Pharma
NAMS
$3.23B
| – | – |
-6,566
|
|
||
503
Neurocrine Biosciences
NBIX
$13B
| – | – |
-3,890
|
|
||
504
Norfolk Southern
NSC
$70.8B
| – | – |
-5,378
|
|
||
505
Pyxis Oncology
PYXS
$104M
| – | – |
-27,345
|
|
||
506
Revolution Medicines
RVMD
$30.1B
| – | – |
-3,036
|
|
||
507
Soleno Therapeutics
SLNO
$2.73B
| – | – |
-3,195
|
|
||
508
Toronto Dominion Bank
TD
$176B
| – | – |
-5,495
|
|
||
509
UFP Technologies
UFPT
$1.49B
| – | – |
-907
|
|
||
510
Universal Health Services
UHS
$10.2B
| – | – |
-1,027
|
|
||
511
Union Pacific
UNP
$157B
| – | – |
-6,266
|
|
||
|
BCAX
512
Bicara Therapeutics
BCAX
$1.41B
| – | – |
-5,039
|
|
||
|
ONC
513
BeOne Medicines Ltd
ONC
$32.2B
| – | – |
-1,408
|
|